Clinical trials
Observational Cerebrovascular Disorders trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
27 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 1 |
| 2001 | 1 |
| 2002 | 1 |
| 2004 | 1 |
| 2007 | 2 |
| 2008 | 3 |
| 2009 | 1 |
| 2011 | 1 |
| 2012 | 1 |
| 2015 | 1 |
| 2016 | 2 |
| 2017 | 3 |
| 2018 | 2 |
| 2022 | 1 |
| 2024 | 1 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 14 |
| Active, not recruiting | 5 |
| Recruiting | 5 |
| Suspended | 1 |
| Terminated | 1 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| National Institute of Neurological Disorders and Stroke (NINDS) | 8 |
| National Heart, Lung, and Blood Institute (NHLBI) | 3 |
| Aventusoft, LLC. | 1 |
| CAMC Health System | 1 |
| Cedars-Sinai Medical Center | 1 |
| Johns Hopkins University | 1 |
| Justin Fraser | 1 |
| Mayo Clinic | 1 |
| Medtronic Neurovascular Clinical Affairs | 1 |
| National Institute on Aging (NIA) | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Cerebrovascular Disorders | 27 |
| Stroke | 15 |
| Cardiovascular Diseases | 6 |
| Ischemic Stroke | 5 |
| Brain Diseases | 4 |
| Ischemic Attack, Transient | 4 |
| Nervous System Diseases | 4 |
| Vascular Diseases | 4 |
| Aneurysm | 3 |
| Diabetes Mellitus | 3 |
Trials
Showing 1 to 25 of 27. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.